Notre Dame, IN – A promising development in cancer research could lead to more effective immunotherapy treatments with fewer harmful side effects after scientists at the University of Notre Dame and Stanford University developed a method that targets immune-suppressing cells inside tumors.
According to research published in Nature Chemical Biology and highlighted by the University of Notre Dame, scientists developed a treatment approach called Tumor Immune Cell Targeting Chimeras, or TICTACs, designed to improve the immune system’s ability to attack cancer.
The research, published in July 2026, showed encouraging results in laboratory experiments and mouse models involving B-cell lymphoma…